Search clinical trials for: Relapsed /Refractory

Total 6317 results

Dutch Childhood Oncology Group
St. Jude Children's Research Hospital; International BFM Study Group

Completed

Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Nanjing Miracle Biotechnology Co., Ltd.
Jiangxi Provincial Cancer Hospital

Not yet recruiting

A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies

Hematological Malignancies

China
Nanjing Miracle Biotechnology Co., Ltd.
The First Affiliated Hospital of Nanchang University

Not yet recruiting

A Phase I, Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematological Malignancies

Hematological Malignancies

China
Shanghai Junshi Bioscience Co., Ltd.

Not yet recruiting

A Randomized, Open-Label, Multicenter Phase III Clinical Study of JS203 Plus Chemotherapy Versus Rituximab Plus Chemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

China
Suzhou Immunofoco Biotechnology Co., Ltd

Not yet recruiting

Dose-Escalation/Expansion Study of iMagic in Relapsed/Refractory Hematologic Malignancies

Relapsed/Refractory Hematologic Malignancies

China

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe